Multiple Novel Ceftazidime-Avibactam-Resistant Variants of <i>bla</i><sub>KPC-2</sub>-Positive Klebsiella pneumoniae in Two Patients.
Ontology highlight
ABSTRACT: As the first-line antimicrobial agent for the infection caused by carbapenem-resistant Enterobacterales, ceftazidime-avibactam develops drug resistance during its ever-growing clinical use. In this study, we report multiple novel variants in blaKPC-2-positive Klebsiella pneumoniae from two separate patients during their exposure to ceftazidime-avibactam. For one patient, the blaKPC-2 gene carried by K. pneumoniae mutated into blaKPC-35, blaKPC-78, and blaKPC-33 over the same period, while that for the other patient mutated into blaKPC-79 and further evolved into blaKPC-76 to enhance resistance level, among which blaKPC-76 and bla
SUBMITTER: Shi Q
PROVIDER: S-EPMC9241591 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA